
Related Funds
Fund Name | Location |
Avego Bioscience Capital | - |
Bankers Healthcare Group | Davie, Florida, United States |
BeyondTrust | California, Carlsbad, United States |
Davis Partnership Architects | - |
Dutchess Opportunity Fund | Boston, Massachusetts, United States |
Fibabanka | Istanbul, Istanbul, Turkey |
Griffith Foods | Alsip, Illinois, United States |
JMCR Partners | China, Hong Kong, Hong Kong Island |
Johnsonville Sausage | United States, Watertown, Wisconsin |
Medley Partners | California, San Francisco, United States |
Mission Throttle | Michigan, Southfield, United States |
Oppenheim Pramerica Asset Management | Luxembourg, Luxembourg |
Oxygen Ventures | Australia, Melbourne, Victoria |
Piper Jaffray | Minneapolis, Minnesota, United States |
Shanghai Yijinghui Asset Management | China, Shanghai |
Shanxi Securities | China, Shanxi, Taiyuan |
StartVenture | California, San Francisco, United States |
Suzhou Xiangtang Venture Capital | China, Jiangsu, Suzhou |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Xingshen Zhineng | 08 Aug 2022 | China, Hunan, China | |||
Epigenic Therapeutics | $20M | 07 Aug 2022 | Shanghai, Shanghai, China | ||
Aijie Boya | 24 Apr 2022 | Suzhou, Jiangsu, China | |||
Bluepha | $123M | 10 Jan 2022 | Dongcheng District, Beijing, China | ||
Bluepha | $77M | 09 Aug 2021 | Dongcheng District, Beijing, China | ||
Bluepha | $30M | 27 Jan 2021 | Dongcheng District, Beijing, China | ||
XW Laboratories | $40M | 18 Sep 2020 | Jiang'an District, Hubei |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Xingshen Zhineng | 08 Aug 2022 | China, Hunan, China | |||
Epigenic Therapeutics | $20M | 07 Aug 2022 | Shanghai, Shanghai, China | ||
Aijie Boya | 24 Apr 2022 | Suzhou, Jiangsu, China | |||
Bluepha | $123M | 10 Jan 2022 | Dongcheng District, Beijing, China | ||
Bluepha | $77M | 09 Aug 2021 | Dongcheng District, Beijing, China | ||
Bluepha | $30M | 27 Jan 2021 | Dongcheng District, Beijing, China | ||
XW Laboratories | $40M | 18 Sep 2020 | Jiang'an District, Hubei |